Literature DB >> 6297507

Differential release of plasminogen activator and latent collagenase from mononuclear cell-stimulated synovial cells.

E E Golds, C P Ciosek, J A Hamilton.   

Abstract

Independent studies have previously shown that mononuclear cell supernatants stimulate the release of plasminogen activator and latent collagenase from synovial cell monolayer cultures. Simultaneous secretion of these enzymes could be an important pathway for tissue destruction under inflammatory conditions, since plasminogen activator can cause activation of latent collagenase in the presence of plasminogen. We investigated the kinetics of release of the two enzymes from synovial cells in response to the addition of mononuclear cell supernatants and retinoic acid. Synovial cells derived from osteoarthritic and rheumatoid arthritic patients responded similarly. Plasminogen activator is released within a few hours of stimulation, and secretion usually stops when the stimulus is removed. In contrast, significant amounts of collagenase are secreted only after an initial lag period of 1--2 days, and secretion is sustained long after removal of mononuclear cell supernatant. Another difference in regulation of the secretion of these two neutral proteinases is that the addition of all-trans retinoic acid to the same synovial cell culture elevates plasminogen activator secretion while suppressing that of latent collagenase. Differential regulation of these enzymes under conditions of chronic inflammation may allow for continual accumulation of latent enzyme(s) which are activated during short periods of plasminogen activator release.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6297507     DOI: 10.1002/art.1780260103

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

1.  Inflammatory cytokines induce synthesis and secretion of gro protein and a neutrophil chemotactic factor but not beta 2-microglobulin in human synovial cells and fibroblasts.

Authors:  E E Golds; P Mason; P Nyirkos
Journal:  Biochem J       Date:  1989-04-15       Impact factor: 3.857

2.  Influence of macrophage products on the release of plasminogen activator, collagenase, beta-glucuronidase and prostaglandin E2 by articular chondrocytes.

Authors:  V Evêquoz; J Schnyder; U Trechsel; M Baggiolini; H Fleisch
Journal:  Biochem J       Date:  1984-04-15       Impact factor: 3.857

Review 3.  Mechanisms of Natural Extracts of Andrographis paniculata That Target Lipid-Dependent Cancer Pathways: A View from the Signaling Pathway.

Authors:  Ruth Naomi; Hasnah Bahari; Zhi Yi Ong; Yong Yoke Keong; Hashim Embong; Retnagowri Rajandram; Soo Huat Teoh; Fezah Othman; Rosnani Hasham; Khoo Boon Yin; Priyatharisni Kaniappan; Muhammad Dain Yazid; Zainul Amiruddin Zakaria
Journal:  Int J Mol Sci       Date:  2022-05-26       Impact factor: 6.208

4.  Peripheral blood mononuclear cells stimulate prostacyclin levels of human synovial fibroblast-like cells.

Authors:  J A Hamilton; B J Clarris; J R Fraser; M C Niall
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

5.  Transforming growth factor beta stimulates urokinase-type plasminogen activator and DNA synthesis, but not prostaglandin E2 production, in human synovial fibroblasts.

Authors:  J A Hamilton; D S Piccoli; T Leizer; D M Butler; M Croatto; A K Royston
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

6.  Peripheral blood mononuclear cells stimulate N-acetyl-beta-glucosaminidase levels of human synovial fibroblast-like cells.

Authors:  B J Clarris; J A Hamilton
Journal:  Rheumatol Int       Date:  1985       Impact factor: 2.631

Review 7.  Potential mechanisms for coordinate gene activation in the rheumatoid synoviocyte: implications and hypotheses.

Authors:  C T Ritchlin; R J Winchester
Journal:  Springer Semin Immunopathol       Date:  1989

8.  Plasminogen activators and tiaprofenic acid in inflammation. A preliminary study.

Authors:  G Fibbi; U Serni; M Pucci; R Caldini; L Magnelli; M Del Rosso
Journal:  Drugs       Date:  1988       Impact factor: 9.546

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.